Japanese Pharmacology & Therapeutics (JPT)
Vol. 47 Suppl. 2 2019
■ SYMPOSIUM
Explanatory Commentary on the Contract Template for Investigator-initiated Multicenter
Clinical Trials Adapting the Clinical Trials Act in Japan
G. Kawahira
Jpn Pharmacol Ther 2019; 47 (s2) : s114-7.
Relationships with Pharmaceutical Companies in the Clinical Trials Act
──Development of RACI chart
M. Mori
Jpn Pharmacol Ther 2019; 47 (s2) : s118-21.
To Operate the Clinical Trials Act Properly
(Consideration of Collaborative Clinical Research)
H. Asai
Jpn Pharmacol Ther 2019; 47 (s2) : s122-5.
Study Design and Analysis Methods in Clinical Trials with Genomic Biomarkers
S. Nomura
Jpn Pharmacol Ther 2019; 47 (s2) : s126-8.
Overview of Research Nurses
N. Fujiwara
Jpn Pharmacol Ther 2019; 47 (s2) : s129-31.
Possibility of Collaboration between Research Nurse and Clinical Research Coordinator
Y. Yanagisawa
Jpn Pharmacol Ther 2019; 47 (s2) : s132-3.
■ ORIGINAL ARTICLES
Preparation of Standard Operating Procedures Reflected the Latest Information for Investigator-initiated Clinical Trials
H. Hayashi,et al
Jpn Pharmacol Ther 2019; 47 (s2) : s134-47.
Analysis of the Status of Specified Clinical Trials Using jRCT
(Japan Registry of Clinical Trials)
H. Taruno, et al
Jpn Pharmacol Ther 2019; 47 (s2) : s148-58.
■ BRIEF REPORT
Cross-sectional Survey on Key Knowledge and Skills for Evidence Creation in Pharmaceutical Industry
S. Asada, et al
Jpn Pharmacol Ther 2019; 47 (s2) : s159-65.
■ CASE REPORT
Case Report of Kanazawa University Hospital:
Protocol Sample and Checklist Adapted to Clinical Trials Act
N. Horikawa, et al
Jpn Pharmacol Ther 2019; 47 (s2) : s166-73.
Points to Consider for Implementation of Clinical Trials Act: A Case Study at Shiga University of Medical Science Research Ethics Committee
M. Kurata, et al
Jpn Pharmacol Ther 2019; 47 (s2) : s174-9.
Inquiry about the Physician-initiated Clinical Trial with iPS Cells for Parkinson's Disease:
Evaluation of the Role of a Call Center
A. Kawakami, et al
Jpn Pharmacol Ther 2019; 47 (s2) : s180-6.